UAE scientific paper tests that diagnose diseases in 10 minutes, no laboratory required! , world News

For a success in infectious disease testing, the way healthcare is prescribed in low-resources and remote settings, it has been determined to revolutionize. A team of scientists at New York University Abu Dhabi (NYUAD) has unveiled a paper-based clinical equipment, which is a radial compartmentalized paper chip (RCP-chip), which is capable of detection of diseases in less than 10 minutes. This innovation is a game-changer for fast, inexpensive and portable disease screening without the need of complex laboratory devices or trained personnel.

Endowment of global needs

The RCP -chip was conceived during the early days of the Kovid -19 epidemic, when the world was struggling with a lack of efficient testing methods, especially in areas with limited resources. Mohammad A said, “Our goal was somewhat fast, cheap and easy to use, especially in areas where the lab access is limited,” said Mohammad A. Qasaimeh, Associate Professor of Mechanical Engineering and Bioinizing at Nyuad. Qasaimeh is a senior writer of the study, which led to the development of RCP-Chip.The new tool provides a simple and rapid solution to detect infectious diseases. “It uses a minimum number of reagents and requires only a small sample to run it,” Qasaimeh said, emphasizing the strength and efficiency of the device. This paper-based diagnostic chip can be easily deployed in various settings, from remote villages to urban areas, and health care access can improve significantly.

A versatile clinical tool

While the RCP -chip was originally designed to detect Kovid -19, its capabilities extend far beyond the Koronwirus novel. According to qasaimeh, the device is easily reusable to diagnose other diseases such as chickenpox, dengue, malaria, and more. “With minor amendments, it can be adapted to diagnose a wide range of diseases or even testing hormones and metabolites,” Casym explained. This flexibility keeps RCP-chip as a multi-purpose clinical tool, which can be used from general infectious disease testing to chronic health conditions in various medical fields.“It is really impressive, its real-world ability,” said Pavithra Sukumar, a research accessory and first writer of the study, Nyuad. Sukumar highlighted the ability of the tool, which is important to significantly improve outbreak reactions to enable rapid separation, treatment and control. In situations where the time is of essence, such as in epidemic or epidemic scenarios, rapid tests introduced by RCP-chip can help patients curb the spread of diseases before becoming uncontrollable.

Simple, cost effective and portable

One of the standout features of RCP-Chip is its portability. Unlike traditional clinical devices, which require refined laboratory setups, the chip can be operated with minimal resources. “It requires a heating phase at about 60 ° C, which can easily be obtained with a warm plate or a common home appliances such as an oven,” Casym explained. The simplicity of the design allows for easy transportation and purinogen, ensuring that healthcare workers can use it effectively in limited infrastructure areas.In addition, RCP-Chap uses salivary samples instead of traditional swabs, making it even more convenient and comfortable for patients. “In a short time, you can deploy it for use in almost any area,” Casyime said. This feature was an important inspiration behind the development of the equipment, which aims to reduce time and cost, which was usually associated with traditional clinical methods.

Concept to commercialization

The development of RCP-chip was not without its challenges. Due to the epidemic -related lab access restrictions, the team faced a delay during the initial stages of research. “In the initial stage, we focused on designing the chip and considering the approaches,” Casyime said. This was not until the ban was reduced that the team was able to conduct the intensive test of the device. “After the initial curfew, we were gradually allowed access to labs, and when we deepened the research and started testing the device,” he explained.Despite these challenges, the team successfully filed a patent for the device and launched a startup to commercialize it. Biotech companies have already expressed interest in innovation. “We aim to find investors so that we can continue with the development phase of the device,” Casyime said. Now the focus is to bring the device to the market and further develop its translation capacity, ensuring that it can be optimized for various purposes in the healthcare sector.With the increasing demand for inexpensive and effective clinical equipment, RCP-Chip is ready to play an important role in global healthcare. Its low cost, speed and versatility makes it an ideal solution for resource-limiting settings, providing a very essential option for current test methods.